Portfolio
Bloodscan Biotech
Commercializing the Labyrinth microfluidic chip, engineered to efficiently isolate and purify circulating tumor cells from peripheral blood for both research and cancer diagnostic purposes.(2026)
Camden Space
Commercializing SCD sensors (small enough to fit in the palm of your hand) that provide unparalleled detection of electric charges on spacecraft. The technology can be used to protect satellites from adverse space weather events or space warfare.(2026)
Carbon Scavenger
Helping create the circular carbon economy by capturing CO2 emitted by trains. This also solves the carbon transportation problem by getting the captured carbon to a place where it can be aggregated.(2026)
Connected Traffic Intelligence
Bringing to market software to allow connected and automated vehicle data to be more readily accessible to traffic engineers.(2026)
Corner3d
Commercializing PassFit, a portable 3D anthropometry system measuring standard body dimensions from clothed individuals.(2026)
Enexa Bio
Enexa Bio is engineering precision small molecules for autoimmune disease, led by a biomarker-driven lupus nephritis program.(2026)
General Orbit
Focused on designing and developing applications, simulations, frameworks, for a new hybrid magnetometer and attitude determination and control system (HyMag-ADCS). Initial customers will be government aerospace and space agencies and their tier supplier.(2026)
HealthyLifetime
Bringing to market a program designed to help older adults maintain their independence as they age by improving their quality of life and promoting independent living.(2026)
Intero Biosystems
Developing stem-cell-derived human intestinal organoids containing functioning neurons, blood vessels, muscle, and inner lining of intestine.(2026)
Medication Data Science
Bringing to market a proactive AI-driven solution for detecting medication errors, called SavERx, that layers real-time protection directly into the e-prescription process.(2026)
MELD Health
Commercializing an intuitive pain assessment and patient provider collaboration platform based on groundbreaking pain research using AI.(2026)
OcularDx
Developing a vitreous biopsy needle for ophthalmic applications and an associated biorepository.(2026)
PHIGI
Commercializing swarms of solar-powered, autonomous, and reconfigurable microrobots to support the management of in-orbit assets.(2026)
PreSense Health
Bringing to market an early warning system to identify patients at an increased risk of deterioration. The underlying technology is a software tool called Predicting Intensive Care Transfers and other Unforeseen Events ("PICTURE").(2026)